{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:01:41Z","timestamp":1777536101608,"version":"3.51.4"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPPGH 5342"],"award-info":[{"award-number":["OPPGH 5342"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,9,17]]},"abstract":"<jats:p>\n            Diethylcarbamazine (DEC) is a drug of choice to treat lymphatic filariasis (LF) either used alone or in combination as mass drug administration (MDA) preventive strategies. The objective of this study was to develop a population pharmacokinetics (PK) model for DEC in subjects infected with lymphatic filariasis (LF) compared to healthy individuals, and to evaluate the effect of covariates on the volume of distribution (\n            <jats:italic>V<\/jats:italic>\n            \/\n            <jats:italic>F<\/jats:italic>\n            ) and oral clearance (CL\/\n            <jats:italic>F<\/jats:italic>\n            ) of DEC. This was an open-label cohort study of treatment-naive\n            <jats:named-content content-type=\"genus-species\">Wuchereria bancrofti<\/jats:named-content>\n            -infected (\n            <jats:italic>n<\/jats:italic>\n            \u2009=\u200932) and uninfected (\n            <jats:italic>n<\/jats:italic>\n            \u2009=\u200924) adults residing in the Agboville District of C\u00f4te d\u2019Ivoire.\n          <\/jats:p>","DOI":"10.1128\/aac.00317-21","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T18:23:55Z","timestamp":1627323835000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals"],"prefix":"10.1128","volume":"65","author":[{"given":"Veenu","family":"Bala","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA"},{"name":"Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashpal S.","family":"Chhonker","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constant","family":"Edi","sequence":"additional","affiliation":[{"name":"Centre Suisse de Recherche Scientifique en C\u00f4te d\u2019Ivoire, Abidjan, C\u00f4te d\u2019Ivoire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Bjerum","sequence":"additional","affiliation":[{"name":"Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin G.","family":"Koudou","sequence":"additional","affiliation":[{"name":"Centre Suisse de Recherche Scientifique en C\u00f4te d\u2019Ivoire, Abidjan, C\u00f4te d\u2019Ivoire"},{"name":"Universit\u00e9 Nangui Abrogoua, Abidjan, C\u00f4te d\u2019Ivoire"},{"name":"Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[{"name":"Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"},{"name":"Veterans Affairs Research Service, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-5027","authenticated-orcid":true,"given":"Daryl J.","family":"Murry","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Laboratory, Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, Nebraska, USA"},{"name":"Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006583"},{"key":"e_1_3_3_3_2","first-page":"589","article-title":"Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion","volume":"92","author":"WHO","year":"2017","unstructured":"WHO. 2017. Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion. Wkly Epidemiol Rec 92:589\u2013593.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2147\/RRTM.S125204"},{"key":"e_1_3_3_5_2","first-page":"441","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2015","volume":"91","author":"WHO","year":"2016","unstructured":"WHO. 2016. Global programme to eliminate lymphatic filariasis: progress report, 2015. Wkly Epidemiol Rec 91:441\u2013455.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1179\/136485907X176517"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706854"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ882"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1914262"},{"key":"e_1_3_3_10_2","volume-title":"Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis.","author":"WHO","year":"2017","unstructured":"WHO. 2017. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. Contract no. WHO\/HTM\/NTD\/PCT\/2017.0. WHO, Geneva, Switzerland."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30467-4"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.3.341"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)90972-5"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0035-9203(96)90437-x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0035-9203(97)90405-3"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.03.046"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007325"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0641-x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.05.022"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-016-0371-0"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02193-17"},{"key":"e_1_3_3_22_2","unstructured":"WHO. 2006. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/43545\/9241547103_eng.pdf?sequence=1."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.12.037"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1179\/000349802125001663"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/00912700222011247"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007541"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005163"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-017-0161-6"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22114"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.01.006"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00317-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00317-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:33:49Z","timestamp":1645486429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00317-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,9,17]]}},"alternative-id":["10.1128\/AAC.00317-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00317-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"2021-02-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00317-21"}}